In the European cohort, a 29-year-old female patient was diagnosed with systemic lupus erythematosus had positive serum THSD7A antibody, and in the Boston cohort, a 77 years old male SMN patient had active prostate cancer at the time of the diagnosis of MN. This evidence concerns the gene THSD7A and prostate cancer.